Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature Review
1 min
05.12.2025
This systematic literature review aimed to identify studies assessing the clinical efficacy and real-world effectiveness of current and emerging...
Terapia della Malattia di Fabry: focus su agalsidasi alfa e agalsidasi beta
25.01.2022
La Malattia di Fabry (MF) è una malattia da accumulo lisosomiale X-linked, dovuta al deficit dell’enzima α-galattosidasi A (α-Gal A) con conseguente...